The Discounted Cash Flow (DCF) valuation of Integra Lifesciences Holdings Corp (IART) is (155.85) USD. With the latest stock price at 16.04 USD, the upside of Integra Lifesciences Holdings Corp based on DCF is -1071.7%.
Based on the latest price of 16.04 USD and our DCF valuation, Integra Lifesciences Holdings Corp (IART) is a sell. selling IART stocks now will result in a potential gain of 1071.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.7% - 8.4% | 6.5% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | (1,481.98) - (94.51) | (155.85) |
| Upside | -9339.3% - -689.2% | -1071.7% |